The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables. The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based automated peritoneal dialysis, solid state ablation laser, cryobiopsy system, dual-energy pulsed field and radiofrequency ablation, on-body delivery system for subcutaneous administration, intelligent navigation systems for spinal disorders, thrombectomy technology for peripheral thromboembolic disease, robotic and manual percutaneous dilatational tracheostomy, injectable device for peripheral nerve stimulation, and real-time three-dimensional (3D) ultrasound.

Diagnostics solutions such as RNA-based stool biomarker diagnostics, blood test for early colorectal cancer screening, AI-based non-contact imaging to diagnose stenosis, and AI-powered elastic scattering spectroscopy for skin cancer risk assessment. Implantables such as long acting implantable drug delivery for glaucoma management, implants for brain tumor management, and fully implantable renal replacement therapy. The TOE also addresses questions such as:

• What are the new technologies, advances in R&D, product development, and regulatory matters impacting the growth of areas like wearables, implantables, diagnostics, surgical tools and instrumentation, image guided surgery, drug delivery, patient monitoring, digital health, and medical imaging?
• Which cutting-edge global developments accelerate the growth of medical device and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, imaging technologies, and platforms?
• Is your team equipped with the right growth strategies to capitalize on major technological developments in the MedTech industry?